白内障超声乳化摘除联合人工晶体植入
- 格式:ppt
- 大小:884.00 KB
- 文档页数:11
* 临床研究 *飞秒激光辅助白内障超声乳化摘除联合人工晶体植入术在高度近视合并白内障中的临床效果研究郑吉琦1,马瑞生21.甘肃省康复中心医院眼科,甘肃兰州730000;2.临夏市民族医院眼科,甘肃临夏731100摘要目的分析在高度近视合并白内障患者中使用飞秒激光辅助白内障超声乳化摘除联合人工晶体植入术的具体临床效果。
方法方便选取2018年1月—2023年1月甘肃省康复中心医院收治的550例高度近视合并白内障患者作为研究对象,根据不同的手术方法分为参照组和研究组。
参照组(250例,410眼)使用传统超声乳化人工晶体植入术,研究组(300例,510眼)使用飞秒激光辅助白内障超声乳化摘除联合人工晶体植入术。
比较两组最佳矫正视力(best corrected visual acuity, BCVA)、不同矫正视力眼数占比、并发症发生情况和术后的生活质量评分。
结果术前两组BCVA比较,差异无统计学意义(P>0.05);术后4个月研究组BCVA(0.42±0.06)高于参照组(0.41±0.02),差异有统计学意义(t=2.521,P<0.05)。
术前两组不同矫正视力眼数占比比较,差异无统计学意义(P>0.05);术后4个月研究组矫正视力0.5~<1和≥1占比均大于参照组,差异有统计学意义(P<0.05)。
研究组并发症发生率为4.00%,低于参照组的8.00%,差异有统计学意义(P<0.05)。
术前两组中文版视功能指数量表评分比较,差异无统计学意义(P>0.05);术后,研究组中文版视功能指数量表评分低于参照组,差异有统计学意义(P<0.05)。
结论高度近视合并白内障患者在临床中使用飞秒激光辅助白内障超声乳化摘除联合人工晶体植入术,能够改善患者 BCVA,并发症较少,并能提升患者的视功能生活质量。
关键词飞秒激光;超声乳化;人工晶体;白内障;矫正视力中图分类号R4文献标志码A doi10.11966/j.issn.2095-994X.2023.09.11.45Clinical Effect of Femtosecond Laser Assisted Cataract Phacoemulsification Com⁃bined with Intraocular Lens Implantation in Patients with High Myopia and Cataract ZHENG Jiqi1, MA Ruisheng21. Department of Ophthalmology, Gansu Provincial Rehabilitation Center Hospital, Lanzhou, Gansu Province, 730000 China;2.Department of Ophthalmology, Linxia Nationalities Hospital, Linxia, Gansu Province, 731100 ChinaAbstract Objective To analyze the specific clinical effects of femtosecond laser assisted cataract phacoemulsification combined with intraocu⁃lar lens implantation in patients with high myopia and cataract. Methods A total of 550 patients with high myopia complicated with cataract admitted to Gansu Provincial Rehabilitation Center Hospital from January 2018 to January 2023 were conveniently selected as the study ob⁃jects and divided into the reference group and the study group according to different surgical methods. The control group (250 cases, 410 eyes) received conventional phacoemulsification intraocular lens implantation, and the study group (300 cases, 510 eyes) received femtosec⁃ond laser-assisted cataract phacoemulsification combined with intraocular lens implantation. The best corrected visual acuity (BCVA), the proportion of eyes with different corrected visual acuity, the incidence of complications and the postoperative quality of life scores were com⁃pared between the two groups. Results There was no statistically significant difference in BCVA between the two groups before operation (P> 0.05). 4 months after operation, BCVA in the study group (0.42±0.06) was higher than that in the reference group (0.41±0.02), and the differ⁃ence was statistically significant (t=2.521, P<0.05). There was no statistically significant difference in the proportion of eyes with different cor⁃rected vision between the two groups before surgery (P>0.05). The ratio of corrected visual acuity 0.5~<1 and ≥1 in the study group was收稿日期:2023-09-08;修回日期:2023-09-26作者简介:郑吉琦(1980-),女,硕士,副主任医师,研究方向为白内障、晶状体疾病、ICL手术、干眼。
老年性白内障患者应用超声乳化摘除术联合人工晶体植入术 治疗的临床效果探讨郑元建 朱月莹 袁钊华△(惠州市第六人民医院眼科,广东 惠州 516200)【摘要】目的:探讨老年性白内障患者应用超声乳化摘除术联合人工晶体植入术治疗的临床效果。
方法:研究对象为2014年1月至2020年6月在我院收治的80例老年性白内障患者,按就诊顺序编号,均分为两组,每组各40例。
奇数编号为对照组,偶数编号为观察组。
对照组采取小切口囊外摘除术进行治疗,观察组采取超声乳化摘除术联合人工晶体植入术进行治疗。
比较两组患者治疗前后眼部情况(房角开放度、前房深度以及眼部压力)。
比较两组患者的治疗效果及并发症发生情况。
结果:治疗前两组患者房角开放度、前方深度及眼部压力无明显差异(P>0.05),治疗后观察组房角开放度及眼部压力明显低于对照组(P<0.05),观察组前房深度明显高于对照组(P<0.05)。
观察组治疗有效率明显高于对照组(P<0.05)。
治疗前两组房水蛋白水平无明显差异(P>0.05),治疗后观察组明显低于对照组(P<0.05)。
观察组并发症发生率明显低于对照组(P<0.05)。
结论:对老年性白内障患者应用超声乳化摘除术联合人工晶体植入术进行治疗效果确切,能够有效改善患者眼部状况,减少并发症发生风险,具有一定的安全性,值得临床采纳。
【关键词】老年性白内障;超声乳化摘除术;人工晶体植入术【中图分类号】R779.66 【文献标识码】A 【文章编号】2096-5249(2022)25-0011-05Clinical effect of phacoemulsification combined with iOL implantation for senile cataractZheng Yuan-jian, Zhu Yue-ying, Yuan Zhao-hua△Department of Ophthalmology, The Sixth People's Hospital of Huizhou, Huizhou 516200, Guangdong, China 【Abstract】Objective: To investigate the clinical effect of phacoemulsification combined with iOL implantation in senile cataract patients. Methods: Eighty patients with senile cataract admitted to our hospital from January 2014 to June 2020 were divided into two groups according to the order of treatment, with 40 cases in each group. The odd-numbered group was the control group, and the even-numbered group was the observation group. The control group was treated with extracapsular excision through small incision, and the observation group was treated with phacoemulsification excision combined with iOL implantation. Ocular conditions (Angle openness, anterior chamber depth and ocular pressure) were compared between 2 groups before and after treatment. The treatment effect and complications were compared between the two groups. Results: Before treatment, there were no significant differences in atrial Angle openness, anterior depth and eye pressure between the two groups (P>0.05). After treatment, the atrial Angle openness and eye pressure in the observation group were significantly lower than those in the control group (P<0.05), and the anterior chamber depth in the observation group was significantly higher than that in the control group (P <0.05). The effective rate of observation group was significantly higher than that of control group (P<0.05). There was no significant difference in aqueous humor protein level between the two groups before treatment (P>0.05), and the observation group was significantly lower than the control group after treatment (P<0.05). The complication rate in observation group was significantly lower than that in control group (P<0.05). Conclusion: Phacoemulsification 作者简介:郑元建(1987.06—),男,本科,主治医师,研究方向:眼科临床医学。
超声乳化白内障摘除术联合人工晶状体植入术对慢性原发性闭角型青光眼的治疗效果作者:穆建华来源:《中国当代医药》2014年第04期[摘要] 目的评价慢性原发性闭角型青光眼患者行超声乳化白内障摘除术联合人工晶状体植入术后的疗效。
方法对58例(58眼)慢性原发性闭角型青光眼患者行超声乳化白内障摘除术联合人工晶状体植入术,比较手术前后眼压、前房深度、房角宽度等参数变化。
结果患者眼压由术前的(33.75±4.10)mm Hg降至术后的(16.24±3.72)mm Hg;中央前房深度由术前(1.74±0.32)mm加深至术后的(2.63±0.52)mm,12点位房角宽度由术前的(21.62±2.83)°加宽至术后的(38.79±4.16)°;6点位房角宽度由术前的(23.89±3.54)°加宽至术后的(42.76±3.12)°,手术前后各项参数比较,差异均有统计学意义(P[关键词] 超声乳化技术;原发性闭角型青光眼;眼压;前房[中图分类号] R775.2 [文献标识码] A [文章编号] 1674-4721(2014)02(a)-0045-02慢性原发性闭角型青光眼(chronic primary angle closure glaucoma,CPACG)是临床常见的不可逆性致盲眼科疾病,发病机制尚不十分明确,但研究发现,晶状体因素是致病的主要因素之一[1]。
经过临床实践,晶状体摘除术已被公认为治疗急性闭角型青光眼的有效途径,而慢性闭角型青光眼的房角是进行性损害,本研究对58例(58眼)CPACG患者行超声乳化白内障摘除联合人工晶状体植入手术,并观察了术后眼前段结构狭窄的改善情况,现报告如下。
1 资料与方法1.1 一般资料选取本院2010 年1月~2012 年6月收治的58例(58眼) CPACG患者,其中,男32例,女26例;年龄47~72岁;房角狭窄范围≥180°,病程3~24个月。
老年白内障超声乳化联合人工晶体植入手术的术前准备和术中配合目的:总结超声乳化联合人工晶体植入手术的手术前准备和手术中配合及护理经验。
方法:选择2013年1月-2014年1月我院100例老年白内障超声乳化吸除联合人工晶体植入术患者的临床病历资料作回顾性分析,总结护理经验。
结果:经过术前全身情况检查、眼部检查、心理护理、器械和药品及手术间的准备、手术室护士与术者积极配合和护理,本组100例(135眼)白内障患者麻醉效果满意,均成功用超声乳化头对晶状体核粉碎、吸除并植入了后房型人工晶体,没有发生严重并发症,手术效果良好,患者满意度96%。
结论:手术前准备和手术中配合是手术成功的重要保证。
标签:老年性白内障;超声乳化;人工晶体;眼科手术;护理老年性白内障(senilecataract)是最多的一种白内障类型,是全球性的最主要的致盲原因之一。
该病的发生与年龄密切相关,多见于50岁以上的中、老年人,部分患者在中年出现。
手术是治疗白内障非常有效的方法,对混浊严重影响视力者应以手术治疗为主。
目前白内障手术方法主要有三种[1]:(1)超声乳化白内障吸除联合人工晶体植入手术;(2)现代白内障囊外摘除+人工晶体植入术;(3)白内障囊内摘除手术。
其中,以超声乳化白内障吸除联合后房型折叠式人工晶体植入手术最为先进和流行,它是采用角巩膜小切口进行手术,应用超声乳化仪器将硬的晶状体核粉碎使其呈乳糜状后将之吸出,保留完整的后囊膜,同时可联合人工晶体植入,优点是手术切口小,手术时间短,视力恢复迅速[2]。
本文回顾性分析2013年1月-2014年1月我院100例老年白内障超声乳化吸除联合人工晶体植入术患者的临床资料,总结护理经验。
1.临床资料1.1一般资料:本组老年白内障患者100例(135眼),男56例,女44例;年龄56-78岁,平均(70.5±7.8)岁。
在局部麻醉下行白内障超声乳化吸除联合人工晶体植入术。
合并高血压35例,冠心病32例,糖尿病16例。
白内障超声乳化摘除联合人工晶体植入手术配合超声乳化手术采用的是不需要缝合的小切口术式,他利用先进的超声乳化仪器将白内障粉碎乳化后吸出,最后将人工晶状体植入到原晶状体的位置上,以替代原来浑浊的晶状体。
V级核以下可采用此种手术方式。
对于白内障超声乳化手术而言,晶状体核越硬,所需的超声能量越大,并发症的发生率越大,风险也就加大。
手术室护士对晶状体核硬度、手术医师的习惯提前了解,并及时将超声乳化仪上各功能参数及时调整好,对于手术的顺利进行非常重要。
适用于老年性白内障、并发性白内障等。
(一)手术用物1.常规布类眼科手术包(眼科剖口单1张、治疗巾8张、孔巾1张、手术衣2件)。
2.手术器械眼显微器械1包、白内障显微器械1盒。
3.一次性用物眼科纱布(5张)包、眼科棉签(30根)1包、眼科专用手术膜1张、10ml注射器1副、5ml注射器1副、冲洗针头1根、玻璃酸钠5mg 1支、10-0不可吸收收缝线(需要时)、角膜穿刺刀1把、前房穿刺刀1把、灌注平衡液1袋、液流系统管理包1盒、超声乳化仪手柄1个、超声乳化仪管道1套、抽吸手柄1个、测试腔1个、手套按需准备。
(二)仪器设备1.眼科手术显微镜坚持手术显微镜,确保目镜、物镜镜头清晰。
接通电源、开启电源开关,检查显微镜是否处于功能完好状态。
熟知手术医师双眼情况调节好目镜的屈光度与瞳距。
2.超声乳化仪巡回护士提前将超声乳化仪电源开启,仪器自测完毕后,从菜单中选择当日手术医师的姓名、超声乳化手柄型号、乳化针头直径。
3.手术床(三)手术配合1.手术安全核查患者进入手术室前已完成手术眼别的标识,手术开始前常规手术安全核查,在进行手术安全核查时应注意手术患者腕带与病历和患者描述信息一致。
2.术眼散瞳散瞳药(复方托吡卡胺滴眼液)滴术眼散瞳,散瞳要充分,最好散至6mm以上。
3.手术麻醉用表面麻醉药(盐酸奥布卡因滴眼液)滴入术眼下穹隆内1-2滴,5min 1次,共3次。
根据医嘱,备好人工晶状体、推助器、注射舱。
超声乳化摘除联合人工晶状体植入术中前房注射曲安奈德对复杂性白内障疗效的影响詹邶;王勇;周吕琴;王明睿;戴琰琰;何之城【摘要】Objective To observe the effectiveness and safety of intracameral injection with triamcinolone acetonide in phacoemulsification and intraocular lens (IOL) implantation in those patients with complicated cataract.Methods 79 cases (79 eyes) of patients with complicated cataract,ever treated in our hospital from Jun 2013 to Jun 2015,were selected and divided into the study group (n =40) and the control group (n =39) by means of random number table.The study group (40 eyes) was given intracameral injection with triamcinolone acetonide (2 mg/0.1 mL) after IOL implantation and sodium hyaluronate replacement,while the control group (39 eyes) was given intracameral injection with 0.1 mL equilibrium liquid.The inflammation and exudation in anterior chamber,change of intraocular pressure (IOP) and count of corneal endothelial cells in the patients of both groups were examined and observed,and the postoperative complications of posterior synechia and IOL anterior membrane in the two groups were followed up for 3 months.Results The inflammation reaction in anterior chamber in the study group was significantly lower than that in the control group at 3,7,14 days after operation (x23d =18.89,x27d =23.75,x22w =16.08;P <0.05).There was no significant difference in the postoperative count of corneal endothelial cells between the two groups (F =0.32;P > 0.05),and so was diffefence inthe increase of IOP between them (F =3.23;P > 0.05).After postoperative follow-up of 3 months,posterior synechia and IOL anterior membrane were found in 5 eyes in the control group and were not found in the study group.Conclusion Application of intracameral injection with triamcinolone acetonide in treatment of complicated cataract could inhibit the postopcrative inflammation and exudation in anterior chamber,reduce the occurrence of complications with easy administration and safe and effective therapeutic effects,while affecting IOP and corneal endothelial cells slightly.%目的观察复杂性白内障超声乳化摘除联合人工晶状体植入术中前房注射曲安奈德的有效性及安全性.方法选取2013年6月至2015年6月安徽省第二人民医院收治的复杂白内障患者79例(79只眼),按随机数字表法分为观察组(40例)和对照组(39例),观察组40例(40眼)在植入人工晶体置换前房玻璃酸钠后,前房内注入曲安奈德2 mg/0.1 mL,对照组39例(39眼)前房注入平衡液0.1 mL.观察两组患者前房炎症反应及渗出、眼压、角膜内皮计数情况,随访至术后3个月观察各组是否出现虹膜后粘连及人工晶体前膜等并发症.结果观察组术后3天、7天、2周前房反应低于对照组,差异均有统计学意义(x23d=18.89,x27d=23.75,x22w=16.08,P<0.05).术后角膜内皮计数,两组比较差异无统计学意义(F=0.32,P>0.05),术后两组眼压升高,但差异无统计学意义(F=3.23,P>0.05),随访至术后3个月,对照组出现人工晶体前膜及虹膜后粘连5例,观察组未出现此类并发症.结论超声乳化摘除联合人工晶状体植入术中,前房注射曲安奈德(2 mg/0.1 mL)可抑制复杂性白内障术后前房炎症及渗出,减少术后并发症的发生,疗效稳定,对眼压及角膜内皮无明显影响,给药简单,安全有效.【期刊名称】《安徽医学》【年(卷),期】2017(038)008【总页数】4页(P986-989)【关键词】复杂性白内障;曲安奈德;前房注射【作者】詹邶;王勇;周吕琴;王明睿;戴琰琰;何之城【作者单位】230000 合肥安徽省第二人民医院眼科;230000 合肥安徽省第二人民医院眼科;230000 合肥安徽省第二人民医院眼科;230000 合肥安徽省第二人民医院眼科;230000 合肥安徽省第二人民医院眼科;230000 合肥安徽省第二人民医院眼科【正文语种】中文复杂性白内障[1]是一组合并葡萄膜炎、青光眼、糖尿病、外伤及其他内眼手术等复杂病情的白内障,因其术前已存在血-房水屏障功能障碍,所以再次行白内障手术后常易出现难治性葡萄膜反应,术后常出现前房闪辉、纤维素渗出等情况,最终可导致虹膜后粘连、人工晶体前膜、瞳孔膜闭,人工晶体移位等并发症,严重影响白内障术后的复明效果。